Application of radix bupleuri polysaccharide in preparing medicine for preventing and treating vaccinum influenzae vivum and virus pneumonia
A technology of Bupleurum polysaccharides and influenza A, applied in antiviral agents, drug combinations, respiratory diseases, etc., to achieve the effect of acute lung injury and treatment of acute lung injury
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Take 100g of Bupleurum herb, extract by cold immersion in 95% ethanol, put the dregs in a ventilated place at room temperature to dry, then extract with hot water for 3 times, filter, combine the extracts, concentrate, centrifuge, and the supernatant with S3 Chloroacetic acid removes free protein, centrifuges, and dialyzes the supernatant with water for 3 days, concentrates the dialysate to a small volume, adds ethanol to an alcohol content of 80%, centrifuges, precipitates and freeze-dries to obtain the total polysaccharide, and the product yield is more than 3%. The content exceeds 65%.
[0040] Table 1 shows the yield and content of total polysaccharides in Bupleurum chinensis.
[0041] The Bupleurum medicinal material is selected from Bupleurum chinense DC, Bupleurum scorzonerifolium Willd or Bupleurum smithiivar. parvifolium Wolff.
[0042] Table 1
[0043]
Embodiment 2
[0045] 24 KM mice (16-18g) were randomly divided into 4 groups (A, B, C, D) according to body weight: group A was the normal control group, group B was the H3N2 virus model group, and group C was the Bupleurum polysaccharide group (40mg / kg), D group is Bupleurum polysaccharide 20mg / kg, 6 in every group. Animals in all groups except group A were anesthetized with ether, and infected with 5LD by intranasal drip 50 30 μL of H3N2 virus solution, 30 μL of 1640 culture solution infected by intranasal drip in group A was used as a control; groups C and D were intragastrically administered 2 hours after infection with H3N2, and the doses were 40 mg / kg and 20 mg / kg respectively; at the same time, groups A and B were given 0.5 %CMC was administered intragastrically as a normal and virus control. Dosing once a day for four consecutive days. After 96 hours of H3N2 virus attack, the body weight was weighed, and the eyeballs were removed to collect blood. Carefully cut off the whole lung...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com